Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated

TickerDGXVenueUSSectorHealthcarePrimary listingBeta0.55
$234.9-0.03%
FinScore55

Quest Diagnostics Incorporated is a United States-based company in the Healthcare sector with a market capitalisation of $25.9B. Its FinScore is 55/100; its highest-scoring layer is Momentum (84) and its lowest is Growth (31). The shares trade at 24.4x trailing earnings and are up 35% year to date.

Market cap
$25.9B
P/E (TTM)
24.4x
Dividend yield (TTM)
1.41%
ROE
14.5%

Share price performance

Loading chart…

About Quest Diagnostics Incorporated

www.questdiagnostics.com

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Profile
Sector
Healthcare
Industry
Medical - Diagnostics & Research
HQ
United States
Fiscal year-end
December
Trading currency
USD
Reporting currency
USD
Fundamentals updated
87 days ago
Market
Market cap
$25.9B
Shares outstanding
110.4M
P/E (TTM)
24.4x
Dividend yield (TTM)
1.41%
Beta (issuer)
0.54
Revenue (latest FY)
$11.0B

Revenue breakdown

FY 2025$10.8B
  • Diagnostic Information Services Business
    100.0%$10.8B

FinScore

As of 2026-10-19
Overall55
Quality76
Growth31
Value35
Momentum84
Relative Strength58

Snapshot

Ownership

As of 2026-06-30
Institutional
95.9%
Insider
0.3%
Free float
99.5%
Top-5 institutional holders
30.5%
Shares outstanding
110.4M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Quest Diagnostics Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Quest Diagnostics Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Quest Diagnostics Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Quest Diagnostics Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Quest Diagnostics Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Quest Diagnostics Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.